Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Sirna Remove


December 2014
Su Sa Fr Th We Tu Mo
21 20 19 18 17 16 15

sirna Press Releases

  + XML/RSS  



By BIOO SCIENTIFIC
Bioo Scientific, an Austin, TX-based biotechnology company was honored yesterday with the 2013 General Motors Technology Award for Small Businesses at the 13th Annual Greater Austin Business Awards.

By SMi Group Ltd
SMi's Controlled Release conference returns to London for the 10th year running with an expert speaker faculty and an all-new programme for 2013.

By Mary Ann Liebert, Inc., publishers
Small interfering RNAs (siRNAs) are a potent new drug class that can silence a disease-causing gene, but delivering them to a target cell can be challenging.

By Sinead Murphy
Biocroi, the Dublin-based biotech company has recently received €800k in funding to further its work on a unique range of multi-well microplates. These are for use in drug discovery research in the pharmaceutical and bio industries.

By SMi Group
Join the top 50 Pharma companies as they discuss some of the most prominent issues that stand in the way of the successful harnessing of the vast potential that this process possesses.

By Mary Ann Liebert, Inc., publishers
Despite the Nobel Prize-winning discovery of RNA interference (RNAi) over a decade ago and the billions of dollars spent developing therapeutic applications, delivery issues continue to challenge the field

By Global Information, Inc.
Select Biosciences - RNAi Asia - Register today

By Mary Ann Liebert, Inc., publishers
Small synthetic fragments of genetic material called small interfering RNA (siRNA) can block production of abnormal proteins; however, these exciting new drug candidates can also induce a strong immune response, causing toxic side effects

By Mary Ann Liebert, Inc., publishers
Many recent reports documenting the therapeutic efficacy of short interfering RNAs (siRNAs) in animal models of human disease may actually be describing non-specific therapeutic effects related to the ability of siRNA to activate an immune response.



Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share